Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $9.20 Analyst target: $20.00 Upside: 117.39%
Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States. The company is headquartered in New York, New York.
See the full interactive analysis & chart →Informational only — not investment advice.